Hypertrophic mediators like angiotensin II or Endothelin-1 induce acetylation and nuclear translocation of HMGB1 in NRCM; conversely, maintenance of stable intracellular HMGB1 levels prevent cardiac hypertrophy [110]. Here, HMGB1 is linked to cardiac hypertrophy.